X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (947) 947
Publication (32) 32
Newsletter (30) 30
Book Review (27) 27
Newspaper Article (10) 10
Book Chapter (7) 7
Magazine Article (2) 2
Trade Publication Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pimecrolimus (683) 683
humans (544) 544
dermatology (459) 459
index medicus (338) 338
atopic dermatitis (325) 325
tacrolimus (312) 312
tacrolimus - analogs & derivatives (284) 284
female (254) 254
male (227) 227
calcineurin inhibitors (216) 216
dermatitis, atopic - drug therapy (212) 212
tacrolimus - therapeutic use (194) 194
adult (192) 192
double-blind (181) 181
administration, topical (179) 179
tacrolimus - administration & dosage (176) 176
treatment outcome (158) 158
skin (155) 155
atopic-dermatitis (152) 152
tacrolimus ointment (149) 149
children (145) 145
efficacy (145) 145
pimecrolimus cream 1-percent (142) 142
middle aged (136) 136
dermatitis (127) 127
child (126) 126
eczema (120) 120
safety (115) 115
tacrolimus - adverse effects (110) 110
corticosteroids (105) 105
dermatologic agents - therapeutic use (105) 105
administration, cutaneous (104) 104
immunosuppressive agents - therapeutic use (100) 100
skin diseases (100) 100
long-term management (99) 99
adolescent (98) 98
drug therapy (93) 93
pimecrolimus cream (89) 89
topical calcineurin inhibitors (88) 88
animals (85) 85
immunosuppressive agents - administration & dosage (83) 83
severity of illness index (83) 83
dermatologic agents - administration & dosage (82) 82
care and treatment (79) 79
aged (78) 78
allergy (70) 70
child, preschool (69) 69
pharmacology & pharmacy (65) 65
ointments (64) 64
psoriasis (64) 64
antiinflammatory drug (62) 62
immunology (62) 62
management (62) 62
medicine & public health (62) 62
double-blind method (61) 61
therapy (60) 60
sdz asm 981 (59) 59
topical corticosteroids (58) 58
quality-of-life (56) 56
tacrolimus - pharmacology (55) 55
young adult (55) 55
health aspects (53) 53
infants (53) 53
quality of life (53) 53
immunosuppressive agents - adverse effects (52) 52
vitiligo (51) 51
dermatologic agents - adverse effects (50) 50
treatment (49) 49
adrenal cortex hormones - therapeutic use (48) 48
clinical trials (48) 48
analysis (47) 47
infant (46) 46
adult patients (44) 44
follow-up studies (44) 44
pediatrics (44) 44
topical tacrolimus (44) 44
inflammation (42) 42
risk factors (42) 42
calcineurin (41) 41
diagnosis (41) 41
pharmacology/toxicology (41) 41
pharmacotherapy (41) 41
sdz asm-981 (41) 41
topical pimecrolimus (41) 41
dermatitis, atopic - therapy (39) 39
randomized controlled trials as topic (38) 38
cream (37) 37
atopic eczema (36) 36
calcineurin inhibitor (36) 36
cyclosporine (36) 36
dose-response relationship, drug (36) 36
medicine, general & internal (36) 36
pruritus (36) 36
research (36) 36
skin - drug effects (36) 36
dermatitis, atopic - diagnosis (35) 35
dermatitis, atopic - immunology (35) 35
skin - pathology (35) 35
1-percent (34) 34
elidel (34) 34
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (849) 849
German (56) 56
Korean (22) 22
French (19) 19
Polish (19) 19
Turkish (14) 14
Spanish (9) 9
Portuguese (3) 3
Russian (3) 3
Italian (2) 2
Czech (1) 1
Dutch (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BRITISH JOURNAL OF DERMATOLOGY, ISSN 0007-0963, 04/2012, Volume 166, Issue 4, pp. 861 - 872
Background An unmet need remains for safe and effective long-term treatments of psoriasis. Objectives To evaluate ustekinumab efficacy and safety for up to 3... 
ATOPIC-DERMATITIS | SAFETY | PIMECROLIMUS CREAM | TACROLIMUS OINTMENT | INDEX | DERMATOLOGY
Journal Article
Annals of Dermatology, ISSN 1013-9087, 2013, Volume 25, Issue 2, p. 168
There is as yet no effective and safe treatment for vitiligo. One percent pimecrolimus cream, a topical calcineurin inhibitor, has been tried for the treatment... 
Pimecrolimus | Vitiligo
Journal Article
Journal of Pakistan Association of Dermatologists, ISSN 1560-9014, 12/2018, Volume 28, Issue 4, p. 507
Journal Article
Journal Article
Annals of Dermatology, ISSN 1013-9087, 2011, Volume 23, Issue 3, p. 348
Dermatomyositis (DM) is an idiopathic inflammatory process characterized by proximal muscle weakness and cutaneous lesions, such as the Gottron`s sign,... 
Pimecrolimus | Dermatomyositis
Journal Article
Journal of Pharmaceutical Care, ISSN 2322-4630, 10/2015, Volume 2, Issue 1, pp. 10 - 14
Background: Oral aphthous is one of the most common oral mucosal inflammatory disorders which are very painful. There is no definite medical strategy up to now... 
Aphthous Stomatitis Pimecrolimus Immunomodulation
Journal Article
JDDG - Journal of the German Society of Dermatology, ISSN 1610-0379, 03/2012, Volume 10, Issue 3, pp. 167 - 173
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 08/2012, Volume 26, Issue 8, pp. 1045 - 1060
Journal Article
Voprosy Sovremennoi Pediatrii - Current Pediatrics, ISSN 1682-5527, 2016, Volume 15, Issue 6, pp. 584 - 589
The article analyzes the current data on the pathogenesis of atopic dermatitis. It discusses the role of the damaged dermal barrier structure in the... 
Atopic dermatitis | Pimecrolimus | Children | children | atopic dermatitis | pimecrolimus
Journal Article
Contact Dermatitis, ISSN 0105-1873, 02/2019, Volume 80, Issue 2, pp. 132 - 133
Journal Article
Journal Article